2012 company finally getting clearance fda sell kit selling years rosy veteran reporter single dumbest regulatory strategy seen 13 years covering food drug administration 23andme changed strategy apparently blew fda deadlines effectively annulling clearance process abruptly cut contact agency May adding insult injury company started aggressive know health leaving little doubt underlying medical purpose 23andme personal genome service left agency little alternative action interactions including 14 face face teleconference meetings hundreds email exchanges dozens written communications agency complained provided statistical advice discussed potential risk mitigation strategies tone spurned spouse exasperated angry 23andme putting effort salvaging relationship fda frets accuracy 23andme